SLN
Silence Therapeutics
SLN
SLN
29 hedge funds and large institutions have $110M invested in Silence Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
60% less capital invested
Capital invested by funds: $276M → $110M (-$166M)
Holders
29
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.13M | |
| 2 | +$591K | |
| 3 | +$466K | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$436K |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$174K |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$1.34M | |
| 3 | -$857K | |
| 4 |
Axa
Paris,
France
|
-$777K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$131K |